Chemoinformaics analysis of 13-Hydroxygermacrone
Molecular Weight | 234.339 | nRot | 1 |
Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
Exact Molecular Weight | 234.162 | nRing | 1 |
Solubility: LogS | -3.986 | nHRing | 0 |
Solubility: LogP | 3.9 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 41.3234 |
nHD | 1 | BPOL | 22.9386 |
QED | 0.394 |
Synth | 4.105 |
Natural Product Likeliness | 2.162 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0 |
HIA | 0.026 |
CACO-2 | -4.472 |
MDCK | 0.0000256 |
BBB | 0.289 |
PPB | 0.929645 |
VDSS | 1.827 |
FU | 0.0382334 |
CYP1A2-inh | 0.84 |
CYP1A2-sub | 0.551 |
CYP2c19-inh | 0.831 |
CYP2c19-sub | 0.593 |
CYP2c9-inh | 0.562 |
CYP2c9-sub | 0.859 |
CYP2d6-inh | 0.284 |
CYP2d6-sub | 0.281 |
CYP3a4-inh | 0.13 |
CYP3a4-sub | 0.212 |
CL | 6.436 |
T12 | 0.422 |
hERG | 0.004 |
Ames | 0.239 |
ROA | 0.059 |
SkinSen | 0.95 |
Carcinogencity | 0.943 |
EI | 0.86 |
Respiratory | 0.968 |
NR-Aromatase | 0.057 |
Antiviral | Yes |
Prediction | 0.908116 |